Cargando…
Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI
Background: While the blood–brain barrier (BBB) is often compromised in glioblastoma (GB), the perfusion and consequent delivery of drugs are highly heterogeneous. Moreover, the accessibility of drugs is largely impaired in the margins of the tumor and for infiltrating cells at the origin of tumor r...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377677/ https://www.ncbi.nlm.nih.gov/pubmed/37509598 http://dx.doi.org/10.3390/biomedicines11071957 |
_version_ | 1785079577136070656 |
---|---|
author | Conq, Jérôme Joudiou, Nicolas Ucakar, Bernard Vanvarenberg, Kevin Préat, Véronique Gallez, Bernard |
author_facet | Conq, Jérôme Joudiou, Nicolas Ucakar, Bernard Vanvarenberg, Kevin Préat, Véronique Gallez, Bernard |
author_sort | Conq, Jérôme |
collection | PubMed |
description | Background: While the blood–brain barrier (BBB) is often compromised in glioblastoma (GB), the perfusion and consequent delivery of drugs are highly heterogeneous. Moreover, the accessibility of drugs is largely impaired in the margins of the tumor and for infiltrating cells at the origin of tumor recurrence. In this work, we evaluate the value of methods to assess hemodynamic changes induced by a hyperosmolar shock in the core and the margins of a tumor in a GB model. Methods: Osmotic shock was induced with an intracarotid infusion of a hypertonic solution of mannitol in mice grafted with U87-MG cells. The distribution of fluorescent dye (Evans blue) within the brain was assessed via histology. Dynamic contrast-enhanced (DCE)-MRI with an injection of Gadolinium-DOTA as the contrast agent was also used to evaluate the effect on hemodynamic parameters and the diffusion of the contrast agent outside of the tumor area. Results: The histological study revealed that the fluorescent dye diffused much more largely outside of the tumor area after osmotic shock than in control tumors. However, the study of tumor hemodynamic parameters via DCE-MRI did not reveal any change in the permeability of the BBB, whatever the studied MRI parameter. Conclusions: The use of hypertonic mannitol infusion seems to be a promising method to increase the delivery of compounds in the margins of GB. Nevertheless, the DCE-MRI analysis method using gadolinium-DOTA as a contrast agent seems of limited value for determining the efficacy of opening the BBB in GB after osmotic shock. |
format | Online Article Text |
id | pubmed-10377677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103776772023-07-29 Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI Conq, Jérôme Joudiou, Nicolas Ucakar, Bernard Vanvarenberg, Kevin Préat, Véronique Gallez, Bernard Biomedicines Article Background: While the blood–brain barrier (BBB) is often compromised in glioblastoma (GB), the perfusion and consequent delivery of drugs are highly heterogeneous. Moreover, the accessibility of drugs is largely impaired in the margins of the tumor and for infiltrating cells at the origin of tumor recurrence. In this work, we evaluate the value of methods to assess hemodynamic changes induced by a hyperosmolar shock in the core and the margins of a tumor in a GB model. Methods: Osmotic shock was induced with an intracarotid infusion of a hypertonic solution of mannitol in mice grafted with U87-MG cells. The distribution of fluorescent dye (Evans blue) within the brain was assessed via histology. Dynamic contrast-enhanced (DCE)-MRI with an injection of Gadolinium-DOTA as the contrast agent was also used to evaluate the effect on hemodynamic parameters and the diffusion of the contrast agent outside of the tumor area. Results: The histological study revealed that the fluorescent dye diffused much more largely outside of the tumor area after osmotic shock than in control tumors. However, the study of tumor hemodynamic parameters via DCE-MRI did not reveal any change in the permeability of the BBB, whatever the studied MRI parameter. Conclusions: The use of hypertonic mannitol infusion seems to be a promising method to increase the delivery of compounds in the margins of GB. Nevertheless, the DCE-MRI analysis method using gadolinium-DOTA as a contrast agent seems of limited value for determining the efficacy of opening the BBB in GB after osmotic shock. MDPI 2023-07-11 /pmc/articles/PMC10377677/ /pubmed/37509598 http://dx.doi.org/10.3390/biomedicines11071957 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Conq, Jérôme Joudiou, Nicolas Ucakar, Bernard Vanvarenberg, Kevin Préat, Véronique Gallez, Bernard Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI |
title | Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI |
title_full | Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI |
title_fullStr | Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI |
title_full_unstemmed | Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI |
title_short | Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI |
title_sort | assessment of hyperosmolar blood–brain barrier opening in glioblastoma via histology with evans blue and dce-mri |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377677/ https://www.ncbi.nlm.nih.gov/pubmed/37509598 http://dx.doi.org/10.3390/biomedicines11071957 |
work_keys_str_mv | AT conqjerome assessmentofhyperosmolarbloodbrainbarrieropeninginglioblastomaviahistologywithevansblueanddcemri AT joudiounicolas assessmentofhyperosmolarbloodbrainbarrieropeninginglioblastomaviahistologywithevansblueanddcemri AT ucakarbernard assessmentofhyperosmolarbloodbrainbarrieropeninginglioblastomaviahistologywithevansblueanddcemri AT vanvarenbergkevin assessmentofhyperosmolarbloodbrainbarrieropeninginglioblastomaviahistologywithevansblueanddcemri AT preatveronique assessmentofhyperosmolarbloodbrainbarrieropeninginglioblastomaviahistologywithevansblueanddcemri AT gallezbernard assessmentofhyperosmolarbloodbrainbarrieropeninginglioblastomaviahistologywithevansblueanddcemri |